Analyst Coverage

                  To our knowledge the following list presents the analysts publishing material commenting on Abcam. We provide this list for your convenience only and do not endorse or express any opinion on the reports these analysts publish.

                  Company Analyst
                  Berenberg Charles Weston
                  Investec Andrew Whitney
                  JP Morgan Cazenove David Adlington
                  Numis Securities Stefan Hamill
                  Panmure Gordon & Co Julie Simmonds
                  Peel Hunt Amy Walker
                  RBC Securities Nick Keher
                  Stifel James Mainwaring

                  About Abcam

                  Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

                  Read more +

                  Abcam Products

                  As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

                  Read more +

                  Investor Information

                  Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

                  Read more +

                  Abcam News

                  We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

                  Read more +